BioNexus Gene Lab (BGLC) Price to FCF (2021 - 2026)

BioNexus Gene Lab has disclosed Price to FCF across 6 years of filings, most recently posting 8.56 for Q2 2026.

• In Q2 2026, Price to FCF fell 18.89% year-over-year to 8.56; the TTM figure through Jun 2026 stood at 4.24 (down 146.53% YoY), while the FY2025 annual figure was 3.91, down 81.87% from the prior year.
• Price to FCF came in at 8.56 for Q2 2026 at BioNexus Gene Lab, up from 26.85 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 75804.14 in Q4 2022 to a low of 8900.02 in Q2 2023.
• Average Price to FCF over 5 years is 3415.16, with a median of 10.08 recorded in 2023.
• Year-over-year, Price to FCF soared 9913.43% in 2022 and plunged 786.55% in 2023.
• Over 5 years, Price to FCF stood at 75804.14 in 2022, then sank by 100.02% to 11.6 in 2023, then soared by 299.86% to 23.19 in 2024, then slumped by 67.05% to 7.64 in 2025, then plunged by 212.12% to 8.56 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 8.56 in Q2 2026, 26.85 in Q1 2026, and 7.64 in Q4 2025.